Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study.
breast cancer
ductal breast cancer
histology
in situ breast cancer
lobular breast cancer
vitamin D
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
14 Mar 2022
14 Mar 2022
Historique:
received:
26
12
2021
revised:
09
03
2022
accepted:
11
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Background: Vitamin D (vitD) may be involved in different extraskeletal conditions as well as skeletal muscle diseases. It has been hypothesized that, at least in part, a low level of vitD could contribute to facilitating cancer development. Breast cancer (BC) seems to be associated with low levels of vitD. Materials and methods: This was an observational retrospective evaluation of 87 women (mean age: 54 ± 12 years old) who underwent surgery for the treatment of BC. Our main purpose was to correlate the types of BC and the levels of vitD. Results: A positive significant correlation (R > 0.7) was found between non-invasive carcinoma in situ and 25(OH)D levels and age (R = 0.82, p < 0.05). A positive, but nonsignificant, correlation was reported between invasive ductal carcinoma and 25(OH)D and age (R = 0.45, p > 0.05). A negative but nonsignificant correlation was found between invasive lobular carcinoma and 25(OH)D and age (R = 0.24, p > 0.05). Discussion and Conclusions: We did not find a significant relationship between vitD and BC subtypes. Considering the positive significant correlation between vitD levels and age for in situ BC, although preliminary, our results seem to suggest a possible role of vitD in in situ BC. However, these findings need to be confirmed in larger studies.
Identifiants
pubmed: 35330465
pii: jpm12030465
doi: 10.3390/jpm12030465
pmc: PMC8951751
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Asian Pac J Cancer Prev. 2016;17(S3):43-6
pubmed: 27165206
J Clin Endocrinol Metab. 2011 Jan;96(1):53-8
pubmed: 21118827
Clin Nutr ESPEN. 2019 Apr;30:170-184
pubmed: 30904218
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Endocr Rev. 2019 Aug 1;40(4):1109-1151
pubmed: 30321335
CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95
pubmed: 26431342
Toxicol Sci. 2018 Oct 1;165(2):272-276
pubmed: 30629266
JAMA Netw Open. 2020 Nov 2;3(11):e2025850
pubmed: 33206192
Ann Surg Oncol. 2012 Aug;19(8):2590-9
pubmed: 22446898
JNCI Cancer Spectr. 2021 Aug 31;5(4):
pubmed: 34476342
Nutrients. 2019 Jun 27;11(7):
pubmed: 31252594
Int J Cancer. 2009 Jan 1;124(1):250-5
pubmed: 18839430
Kaohsiung J Med Sci. 2018 Aug;34(8):423-427
pubmed: 30041759
Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):16-26
pubmed: 33002425
J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):195-9
pubmed: 18590821
Asian Pac J Cancer Prev. 2014;15(1):129-32
pubmed: 24528013
J Steroid Biochem Mol Biol. 2018 Jan;175:125-135
pubmed: 28216084
Endocrine. 2019 Aug;65(2):238-243
pubmed: 31231781
Steroids. 2019 Oct;150:108447
pubmed: 31302113
Nutr Rev. 2008 Oct;66(10 Suppl 2):S116-24
pubmed: 18844838
Environ Health Perspect. 2017 Jul 06;125(7):077004
pubmed: 28728134
Breast Cancer Res. 2015 Mar 13;17:37
pubmed: 25848941
Curr Rheumatol Rep. 2008 Apr;10(2):110-7
pubmed: 18460265
Curr Opin Oncol. 2016 May;28(3):205-9
pubmed: 26974846
Ann Agric Environ Med. 2017 Dec 23;24(4):549-553
pubmed: 29284222
JAMA. 2018 Apr 17;319(15):1592-1599
pubmed: 29677309
Bull Cancer. 2020 Jan;107(1):61-71
pubmed: 31564476
N Engl J Med. 2019 Jan 3;380(1):33-44
pubmed: 30415629